University of Exeter
Browse

Influence of inflammation and nitric oxide upon platelet aggregation following deposition of diesel exhaust particles in the airways

Download (781.65 kB)
journal contribution
posted on 2025-07-31, 17:52 authored by E Smyth, A Solomon, MA Birrell, MJ Smallwood, PG Winyard, TD Tetley, M Emerson
BACKGROUND AND PURPOSE: Exposure to nanoparticulate pollution has been implicated in platelet-driven thrombotic events such as myocardial infarction. Inflammation and impairment of nitric oxide (NO) bioavailability have been proposed as potential causative mechanisms. It is unclear, however, whether airways exposure to combustion-derived nanoparticles such as diesel exhaust particles (DEP) or carbon black (CB) can augment platelet aggregation in vivo and the underlying mechanisms remain undefined. We aimed to investigate the impact of acute lung exposure to DEP and CB upon platelet activation and the associated role of inflammation and endothelial-derived NO. EXPERIMENTAL APPROACH: DEP and CB were intratracheally instilled into wild-type (WT) and eNOS(-/-) mice and platelet aggregation was assessed in vivo using an established model of radiolabelled platelet thromboembolism. The underlying mechanisms were investigated by measuring inflammatory markers, NO metabolites and light transmission aggregometry. KEY RESULTS: Platelet aggregation in vivo was significantly enhanced in WT and eNOS(-/-) mice following acute airways exposure to DEP but not CB. CB exposure but not DEP, was associated with significant increases in pulmonary neutrophils and IL-6 levels in the bronchoalveolar lavage fluid and plasma of WT mice. Neither DEP nor CB affected plasma nitrate/nitrite concentration and DEP-induced human platelet aggregation was inhibited by an NO donor. CONCLUSIONS AND IMPLICATIONS: Pulmonary exposure to DEP and subsequent platelet activation may be implicated in the reported increased cardiovascular risk associated with exposure to airborne pollution independent of its impact on inflammation or NO bioavailability.

Funding

This work was supported by a Project Grant from the British Heart Foundation (PG/10/80/28605) awarded to M Emerson and T D Tetley.

History

Related Materials

  1. 1.

Notes

This is the author accepted manuscript. The final version is available from Wiley via the DOI in this record.

Journal

British Journal of Pharmacology

Publisher

Wiley / British Pharmacological Society

Place published

England

Language

en

Citation

Published online 24 April 2017

Department

  • Archive

Usage metrics

    University of Exeter

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC